World health organization has recommended albendazole mechanisms of improved dissolution of ABZ from SDs. (ABZ) as an adjunct as well as alternative to surgery for the management of hepatic and pulmonary echinococcosis Adsorbent carriers have been recommended previously caused by Echinococcus granulosus 1 . Systemic absorption for size reduction of drug particles during preparation of of this drug is warranted also during the treatment of SD 8 . Recently, researchers have also reviewed methods extra-ocular and cerebral cysticercosis, though the most for preparing molecular dispersion (solid solution) effective treatment for the latter is debated [2] [3] [4] . ABZ employing different carriers 9 . However, only few reports belongs to biopharmaceutical classification system (BSC) include experiments trying to measure or confirm particle type II (low aqueous solubility with high permeability) [5] [6] . size reduction of drug in the SD [10] [11] [12] . The present study Preparation of ABZ solid dispersion (SD) by solvent evaporation method using an amorphous carrier (polyvinylpyrrolidone) at 1:10, 1:20 and 1:40 (drug-carrier) ratios; X-ray diffraction (XRD) patterns; solubility and dissolution profiles of the same have been reported earlier 7 . The aim of the present task was to prepare amorphous dispersion of ABZ in crystalline carriers, namely, urea, polyethylene glycol 6000 (PEG) and poloxamer 407 (PXR), and to study the extent of inhibition of drug recrystallization as well as other *For correspondence E-mail: kalaipharmacy@yahoo.com has been designed to examine the particle size of drug in SD using a novel dissolution technique as an adjunct to routine evaluation methods meant for assessing solubility, wettability, crystallinity, drug-carrier interaction and morphology.
MATERIALS AND METHODS
The following materials were used: ABZ (gift sample from Juggat Pharma, Bangalore, India), mebendazole (gift sample from Cadila Pharmaceuticals Ltd., Ahmedabad, India), urea and polyethylene glycol 6000 (Qualigens, Mumbai, India), poloxamer 407 (gift sample from BASF India Ltd., Chennai, India). All other materials used were www.ijpsonline.com of either HPLC or analytical grade.
Formulations:
Physical mixture (PM) was prepared by mixing ABZ with urea or PEG or PXR for 5 min at 1:1, 1:3 and 1:5 weight ratios using glass mortar and pestle. Melting method (MM), solvent method (SM) and kneading method (KM) were followed for the preparation of SDs 13-14 . The procedures are given below in the same order:
The PM was heated by stirring at 190-200° in an oil bath Samples were withdrawn, filtered through a membrane filter (0.45 µm), diluted with water and analyzed in a spectrophotometer (UV-1601PC, Shimadzu) at 291 nm.
Contact angle:
Sample powder from pure drug or PM or SD (300 mg) was compressed into a pellet by a hydraulic press at 5000 kg/cm 2 pressure (1 min) (KP 462, Kimaya Engineering, Thane, India). Water (20 µl) was placed from a micro syringe on the pellet surface, and the drop was photographed after 3 s for the determination of contact to achieve a homogenous dispersion. When the solid was angle as described preveously [17] [18] completely dissolved, the hot liquid was shifted to a water bath (99°) with continued stirring. It was then subsequently Thermal analyses: cooled to 25°. The congealed mass was pulverized, Thermal analyses were carried out as reported passed through 30 mesh, stored in a vacuum desiccator previously [13] [14] . Differential scanning calorimetry (DSC) for (12 h) and passed through 60 mesh before packaging in all powder samples was performed on a differential an airtight container.
scanning calorimeter (DSC-60, Shimadzu, Japan) using 2-4 mg of sample in a closed aluminium pan at a heating rate The PM was dissolved in a minimal volume of anhydrous of 5°/min from 35 to 300° under a nitrogen purge of 40 methanol, and the solvent was removed by slow ml/min. TA 60WS software (version 1.4, Shimadzu, Japan) evaporation under reduced pressure. The dried cowas used. precipitate was passed through 30 mesh, stored in a vacuum desiccator (48 h) and passed through 60 mesh
In order to evaluate the presence of residual solvent in before packaging in an airtight container.
the SDs, thermogravimetric analysis (TGA) was performed. Samples (10-12 mg) were placed in open pans The PM was triturated using a small volume of methanoland heated at a rate of 10°/min under nitrogen purge (40 water (1:1) solution to give a thick paste, which was ml/min) from room temperature to 110°. Subsequently, the kneaded (30 min) and then dried at 45° in an oven. The samples were kept isothermally (5 min) at 110°. Weight dried mass was pulverized, passed through 30 mesh, stored loss occurring between ambient temperature and 110° was in a vacuum desiccator (48 h) and passed through 60 mesh considered to be the weight of residual solvent. before packaging in an airtight container. When methanol alone was used for kneading, the thick paste got dried Powder X-ray diffraction: immediately. To avoid drying of the solvent during XRD was carried out for all preparations and pure drug kneading, methanol was previously mixed with water (1:1) employing a CuK α source operating at 40 kV, 20 mA, 3°/ and then used for the kneading process. The SDs blocked min scanning rate and 3° to 40° (2θ) range (JDX 8030, the 60 mesh screen unless passed previously through 30 Jeol, Japan). The positions and intensities of diffraction . mesh and dried in a vacuum desiccator.
Assay of drug content:
The drug content of SD or PM was determined spectrophotometrically by dissolving the sample in glacial acetic acid, followed by sufficient dilution with water to measure the absorbance at 291 nm (UV-1601PC, Shimadzu)
15
.
Phase solubility study:
Phase solubility study for ABZ was performed as described by Higuchi and Connors 16 . Excess amount of ABZ was added to aqueous solutions containing the carrier at various concentrations and shaken for 96 h at 25 and 37°. peaks were considered for the identification and comparison of crystallinity of the drug or carrier 18 .
Infrared spectroscopy:
Fourier transform infrared (FTIR) spectra were obtained on a Perkin-Elmer Fourier transform infrared spectrophotometer (Spectrum one B 68718, USA) with a resolution of 2 cm -1 from 4000 to 400 cm -1 . KBr pellets were prepared by gently mixing the sample with KBr (1:100 ratio).
Particle size analysis and scanning electron microscopy: Particle size and size distribution of the pure drug sample electron microscope (JSM-5610 LV, Jeol, Japan). Images were recorded at 800 times magnification.
www.ijpsonline.com was determined using a laser scattering particle size analyzer (Horiba LA -910, Japan). The morphology of pure drug, PM and SDs was studied using a scanning
Concentration of carrier materials (%)
India) with an agitation of 50 rpm for 2 or 8 h. To avoid floating, the sample was clamped between infusion filter ABZ solubility (µg/ml)
Dissolution study:
In vitro dissolution studies for all preparations and pure drug equivalent to 20 mg of ABZ were carried out in 900 ml of distilled water at 37° using USP XXIII type 2 dissolution apparatus (TDT-06P, Electrolab, Mumbai, paper pieces and immersed in the dissolution medium. . The filtered sample (0.5 ml) in a 15 ml test tube was mixed with 3 ml of borate potential emulsifier and solubilizer in pharmaceutical buffer (pH 10.5) (5 min) and chloroform (4 ml) using a preparations
20
. Recently this polymer has also been used vortex mixer. It was then centrifuged at 2500 rpm (10 as a solid dispersion carrier 14, 21 . There was a rise in the min). Chloroform layer (2 ml) was transferred to another solubility when the study temperature was reduced from test tube, and the solvent was evaporated to dryness in 37 to 25°. The exothermic nature of the solubility vacuum at 40°. The residue in the tube was reconstituted enhancement predicted hydrogen bond formation with acetonitrile (0.1-0.2 ml) containing mebendazole as an between drug and carrier, since a rise in temperature internal standard (1 µg/ml) and injected (20 µl) into an disfavours hydrogen bonding. This finding was also supporting the choice of these carriers in situations where they would prevent the mobility of drug molecules to The samples were analyzed following HPLC method reunite and recrystallize during formation of SD. Similar reported previously 19 . A liquid chromatograph (LChydrogen bonding is possible in the SD also when the 10ADVP, Shimadzu, Japan) equipped with a variable drug is molecularly dispersed in a carrier (solid solution). wavelength UV detector (SPD-10A, Shimadzu), a Wettability was significantly improved in all SDs compared Rheodyne injector valve (model 7125) and a Supelcosil to pure drug ( fig. 2 ). Mixing ratio and method of ODS analytical column (5 µm, 0.46 cm × 25 i.d.) was used. preparation had only a slight effect on the contact angle. The mobile phase consisted of a 0.05 M phosphate PEG systems showed the best wettability, whereas PXR buffer (pH 7.0)-acetonitrile (55:45), and the pH of the systems had relatively less wettability among the same was adjusted to 6.5 using phosphoric acid. The flow dispersions prepared. rate was 1.0 ml/min, and the detection was at 310 nm.
HPLC system. Fig. 1 shows solubility profile of ABZ influenced by carrier material concentrations at two different temperatures. Both PEG and urea exhibited similar effect on the solubility, while PXR showed an enormous improvement. There was a requirement of minimum concentration of PXR (0.75%) to exhibit the solubility enhancement. This might be attributed to its surface-active property and critical micelle concentration. PXR is a polyoxyethylene-polypropylene block copolymer (structurally related to PEG) non-ionic surfactant with a hydrophilic-lipophilic balance value of 18-23 used as Fig. 3 shows DSC thermograms. Pure drug, PM and SDs of 1:1 drug:carrier ratio had an endothermic peak at 195 200°, corresponding to melting of ABZ. Such melting peak with ABZ-PXR dispersions of 1:1 ratio was not as sharp as observed with ABZ-urea or ABZ-PEG systems, signifying that drug solubility in PXR is relatively high. SDs in urea or PEG or PXR of 1:3 ratio, regardless of the method of preparation, showed a broad endotherm (not shown) at a temperature lower than the melting point of ABZ. The SDs of 1:5 drug:carrier ratio, irrespective of the method of preparation, showed almost disappearance of drug peak, suggesting two possibilities -namely, amorphous precipitation of the drug and better solubilization in the carrier.
RESULTS AND DISCUSSION
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www.ijpsonline.com products of SM and 0.3-0.2% for KM. The solvent was thought to consist mainly of water, as the thermograms showed no sign of methanol evaporation at 65° and PMs themselves showed a loss of weight (less than 0.1%) during the analysis. Samples passed the residual solvent test recommended for methanol (Class 2 solvent) 23 .
The XRD patterns of pure drug, PMs and SDs are illustrated in fig. 4 . ABZ exhibited characteristic intense diffractions at 2θ of 11.3°, 18.0°, 19.5°, 25.2° in addition to a hallow pattern at 5°-11°. Urea had a more intense peak at . Degree of recrystallization was relatively high with KM, as noticed in the XRD pattern of the dispersions in all carriers used. The lower intensity of the drug peaks in the PM with high carrier content is due . Urea showed a doublet band of N-H stretch at 3350-3450 cm -1 . Two intense bands at 1680 and 1626 cm -1 occurred due to carbonyl absorption (amide I band) and NH 2 scissoring vibrations respectively. SDs of 1:1 ratio and the corresponding PMs showed superimposed spectra of ABZ and urea. A slight reduction in the carbonyl frequency of urea was noticed as the proportion of urea was increased in ABZ-urea dispersions compared to corresponding PMs. This
The TGA was performed to determine the amount of residual methanol to assure the safe use of products, because of the fact that ABZ is used for a prolonged time period over several weeks in the treatment of echinococcosis 22 . The weight percentage of residual solvent was determined to be less than 0.2% for the . SDs of 1:1 ratio and the corresponding PMs showed superimposed spectra of ABZ and PEG. The transmittance intensities of N-H stretching band of ABZ were reduced markedly and shifted to 3340 cm -1 in SDs with PEG of 1:3 and 1:5 mixing ratios, while the same band was also disappearing with MM at 1:5 ratio. The broad OH stretching band of PEG slightly shifted to lower frequency in these products. Reduction in intensity of transmittance occurred also for NH bending vibrations of ABZ (1525-1630 cm -1 ) in 1:3 and 1:5 ABZ-PEG dispersions. Similar observations were also obtained with PXR dispersions, which might be due to similarity of the groups of polymers 14, 20 . From these results, it can be speculated that drug-carrier hydrogen bonding existed in these SDs, causing reduced drug recrystallization 26 .
The mean particle size of pure drug sample was calculated to be 10. ) .
PM also due to the presence of diffusion layer of high carrier concentration around the drug particles 27 . The solubilized drug diffuses to and gets diluted in the bulk of the dissolution medium. This experimental setup offers the possibility to verify the drug particle size reduction in an SD by comparing its dissolution profile to that of corresponding PM with the same drug content and known particle size 27 . The higher the dissolution of SD, the higher must be the size reduction of the dispersed drug. The combined effect of particle size reduction, solubilization and wettability on dissolution can be understood by comparing the dissolution profile of SD with that of pure drug. Though hot-stage microscopy has been used recently for the drug particle size examination size compared to the carrier particles, and they remained agglomerated with reduced effective surface area. They remained dispersed and physically adsorbed on the surface of carrier particles in the PM. The micrograph of the ABZ-PXR melt (1:5 ratio) showed a homogeneity, hinting ABZ molecules could be dispersed uniformly in the carrier matrices of SDs prepared by melting method at 1:5 ratio, assuming amorphous solid dispersion state.
In the dissolution study, clamping of powder samples between filter paper means that in the case of PM, the carrier would stay close to and dissolve in contact with the drug particles almost to the same extent as that of SD. Wettability and solubilization of drug are improved in the in SD, it is not superior to the above-mentioned method in confirming the particle size reduction. The microscopic analysis involves heating of SD to reduce the carrier viscosity, improving its transparency leading to visibility of dispersed particles; but this would also allow the smaller particles to dissolve in the hot carrier, leaving only the coarser ones to be analyzed 12 . In the present study, the sample enclosed in the filter paper did not float in the dissolution medium and hence the rotating paddle apparatus was used for the dissolution studies.
Dissolution followed first-order kinetics during the period of 0-45 min. Fig. 7 illustrates the dissolution rate constant (K 1 ) and dissolution efficiency (DE 120 ) calculated as per . With all carriers, SDs had greater dissolution rates and efficiencies than the corresponding PMs and pure drug, for which the dissolution rate constant and DE were 0.000713 min -1 120 and 3.844% respectively. Both dissolution rate and dissolution efficiency depended on the method of preparation and mixing ratio.
The drug crystallinity was reduced in kneaded mass at 1:1 drug:carrier ratio as per the XRD report. But this reduction did not result in any important dissolution improvement, probably due to insignificant size reduction. To clarify the differences in dissolution rate and dissolution efficiency, a two-way analysis of variance (ANOVA) was performed. The melts, as well as the co-precipitates with all
. m e d k n o w fig. 8 ). The ABZ-PXR melt (1:5 ratio) showed the most remarkable dissolution improvement -16.1-fold in dissolution rate and 9.4-fold in dissolution efficiency as compared to that of pure drug. Melting method with all the carriers showed around 4-fold improvement in dissolution rate and 3-fold dissolution efficiency compared to the corresponding PM (P < 0.05). As the products were similarly superior to the PM, the extent of particle size reduction might also be almost same with all carriers for this mixing ratio and method of preparation. However, with respect to the solvent method, improvement in the dissolution rate and efficiency varied with the carriers used, PXR system showing the fastest dissolution with respect to PM (P < 0.05). The kneaded products at the same mixing ratio showed only small improvement (50 80%) relative to PM.
In all mixing ratios used, melting method exhibited the maximum dissolution rate and efficiency (P < 0.05) compared to the PM or pure drug. The relative efficiency of the various methods of preparation with respect to the extent of particle size reduction can be ranked as MM>SM>KM. Such ranking with respect to drug crystallinity using DSC analysis was not possible, especially at 1:5 mixing ratio, presumably due to dissolution of drug particles in the carrier while heating in carriers used when compared to pure drug (P < 0.05). Time in min % ABZ Dissolved PXR the carriers and mixing ratios, had significantly improved dissolution rates than the corresponding PM and pure drug (P < 0.05), assuming that size reduction of drug particles in these SDs was significant. Among the three carriers, PXR showed the highest dissolution rate and efficiency with respect to pure drug for all mixing ratios and methods of preparation (P < 0.05).
As the 1:5 mixing ratio showed the most significant improvement in dissolution rate and DE 120 values for all carriers and preparation methods, the profiles are DSC ( fig. 3) . The proportion of carrier in the SD had a positive influence on the inhibition of drug recrystallization and extent of particle size reduction. As the carrier concentration increased, the influence of MM and SM on drug particle size got raised and the corresponding change in crystallinity could not be observed with XRD technique due to dilution effect 24 . For the given method of preparation and mixing ratio, the degree of particle size reduction might be similar in all carriers. The relative dissolution potency of the carriers compared to the pure drug might be ranked as PXR>PEG>urea. Though the PXR systems exhibited relatively low wettability, ABZ-PXR melt at 1:5 mixing ratio showed the highest dissolution efficiency among the This is because of its highest solubilization effect (in the diffusion layer) as observed in the phase solubility study. Joshi et al. recently reported the beneficial effects of the incorporation of a surfactant (Tween 80) into SDs 29 . The improved wettability might be the major contributing factor for the enhanced dissolution of ABZ-PEG system though particle size also played a significant role in dissolution enhancement.
When the dissolution for the products of 1:5 drug:carrier ratio was continued for 8 h, ABZ, from the melt and co precipitates, was dissolved over its solubility (10.5 µg per ml of distilled water containing 0.01% carrier material). Post-peak decline was noticed due to precipitation of the dissolved www.ijpsonline.com amorphous drug. Such effect was also reported earlier for piroxicam-polyethylene glycol 4000, nifedipine-polyethylene glycol 6000 and nifedipine-hydroxypropylmethyl cellulose dispersions [30] [31] . This has been described as supersaturation phenomenon caused by amorphous drug [32] [33] . Supersaturation is an event of increase in the drug concentration beyond the solubility level during the dissolution of an amorphous drug, which is well perceptible under nonsink conditions 33 . An initial increase in the solubility followed by crystallization of the dissolved drug confirms the amorphous nature of the drug in the SDs of present investigation.
